Comparative studies of the estrogen receptors β and α and the androgen receptor in normal human prostate glands, dysplasia, and in primary and metastatic carcinoma

American Journal of Pathology

Volumn 159, Issue 1, 2001, Pages 79-92

  Leav, Irwin ^a   Lau, Kin Mang ^b   Adams, Jason Y ^a   McNeal, John E ^c   Taplin, Mary Ellen ^b   Wang, Jianfu ^d   Singh, Hema ^d   Ho, Shuk Mei ^b  

^a TUFTS UNIVERSITY   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^d Biogenex Laboratories   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; MESSENGER RNA;

AGED; ARTICLE; CARCINOMA; COMPARATIVE STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; HUMAN; IMMUNOCHEMISTRY; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; METASTASIS; MIDDLE AGED; PATHOLOGY; PROSTATE; PROSTATE DISEASE; PROSTATE TUMOR; REFERENCE VALUE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

AGED; BLOTTING, WESTERN; CARCINOMA; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; HUMANS; IMMUNOCHEMISTRY; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROSTATE; PROSTATIC DISEASES; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; RECEPTORS, ESTROGEN; REFERENCE VALUES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0035408472     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)61676-8     Document Type: Article

References (51)

1. Grayhack JT, Keeler TC, Kozlowski JM: Carcinoma of the prostate. Hormonal therapy. Cancer 1987, 60:589-601
2. Kozlowski JM, Ellis WJ, Grayhack JT: Advanced prostatic carcinoma Early versus late endocrine therapy. Urol Clin N Am 1991, 18:15-24
3. Huggins C, Hodges CV: Studies on prostatic cancer. I. The effect of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate. CA Cancer J Clin 1972, 22:232-240
4. Helpap B, Stiens R: The cell proliferation of epithelial metaplasia in the prostate gland. An autoradiographic in vitro study. Virchows Arch B Cell Pathol 1975, 19:69-76
5. Leav I, Merk FB, Ofner P, Goodrich G, Kwan PW, Stein BM, Sar M, Stumpf WE: Bipotentiality of response to sex hormones by the prostate of castrated or hypophysectomized dogs. Direct effects of estrogen. Am J Pathol 1978, 93:69-92
6. Merk FB, Warhol MJ, Kwan PW, Leav I, Alroy J, Ofrer P, Pinkus GS: Multiple phenotypes of prostatic glandular cells in castrated dogs after individual or combined treatment with androgen and estrogen. Morphometric, ultrastructural, and cytochemical distinctions. Lab Invest 1986, 54:442-456
7. Mawhinney MG, Neubauer BL: Actions of estrogen in the male. Invest Urol 1979, 16:409-420
8. Levine AC, Kirschenbaum A, Droller M, Gabrilove JL: Effect of the addition of estrogen to medical castration on prostatic size, symptoms, histology and serum prostate specific antigen in 4 men with benign prostatic hypertrophy. J Urol 1991, 146:790-793
9. De Marzo AM, Nelson WG, Meeker AK, Coffey DS: Stem cell features of benign and malignant prostate epithelial cells. J Urol 1998, 160: 2381-2392
10. Ho SM, Lee KF, Lane K: Neoplastic transformation of the prostate. Prostate: Basic and Clinical Aspects. Edited by RK Naz. Boca Raton, CRC Press 1997, pp 73-113
11. Bosland MC: The role of steroid hormones in prostate carcinogenesis. J Natl Cancer Inst Monogr 2000, 2000:39-66
12. Santti R, Newbold RR, Makela S, Pylkkanen L, McLachlan JA: Developmental estrogenization and prostatic neoplasia. Prostate 1994, 24:67-78
13. Pylkkanen L, Makela S, Santti R: Animal models for the preneoplastic lesions of the prostate. Eur Urol 1996, 30:243-248
14. Leav I, Ho SM, Ofner P, Merk FB, Kwan PW, Damassa D: Biochemical alterations in sex hormone-induced hyperplasia and dysplasia of the dorsolateral prostates of Noble rats. J Natl Cancer Inst 1988, 80: 1045-1053
15. Bosland MC, Ford H, Horton L: Induction at high incidence of ductal prostate adenocarcinomas in NBL/Cr and Sprague-Dawley Hsd:SD rats treated with a combination of testosterone and estradiol-17 beta or diethylstilbestrol. Carcinogenesis 1995, 16:1311-1317
16. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA: Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 1996, 93:5925-5930
17. Mosselman S, Polman J, Dijkema R: ER beta: identification and characterization of a novel human estrogen receptor. FEBS Lett 1996, 392:49-53
18. Tremblay GB, Tremblay A, Copeland NG, Gilbert DJ, Jenkins NA, Labrie F, Giguere V: Cloning, chromosomal localization, and functional analysis of the murine estrogen receptor beta. Mol Endocrinol 1997, 11:353-365
19. Bhat RA, Harnish DC, Stevis PE, Lyttle CR, Komm BS: A novel human estrogen receptor beta: identification and functional analysis of additional N-terminal amino acids. J Steroid Biochem Mol Biol 1998, 67:233-240
20. Enmark E, Pelto-Huikko M, Grandien K, Lagercrantz S, Lagercrantz J, Fried G, Nordenskjold M, Gustafsson JA: Human estrogen receptor beta-gene structure, chromosomal localization, and expression pattern. J Clin Endocrinol Metab 1997, 82:4258-4265
21. Kuiper GG, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S, Gustafsson JA: Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 1997, 138:863-870
22. Paech K, Webb P, Kuiper GG, Nilsson S, Gustafsson J, Kushner PJ, Scanlan TS: Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. Science 1997, 277:1508-1510
23. Enmark E, Gustafsson JA: Oestrogen recept - an overview. J Intern Med 1999, 246:133-138
24. Gustafsson JA: Estrogen receptor beta - a new dimension in estrogen mechanism of action J Endocrinol 1999, 163:379-383
25. Chang WY, Prins GS: Estrogen receptor-beta: implications for the prostate gland. Prostate 1999, 40:115-124
26. Krege JH, Hodgin JB, Couse JF, Enmark E, Warner M, Mahler JF, Sar M, Korach KS, Gustafsson JA, Smithies O: Generation and reproductive phenotypes of mice lacking estrogen receptor beta. Proc Natl Acad Sci USA 1998, 95:15677-15682
27. Poelzl G, Kasai Y, Mochizuki N, Shaul PW, Brown M, Mendelsohn ME: Specific association of estrogen receptor beta with the cell cycle spindle assembly checkpoint protein, MAD2. Proc Natl Acad Sci USA 2000, 97:2836-2839
28. Lau KM, LaSpina M, Long J, Ho SM: Expression of estrogen receptor (ER)-alpha and ER-beta in normal and malignant prostatic epithelial cells: regulation by methylation and involvement in growth regulation. Cancer Res 2000, 60:3175-3182
29. Montano MM, Jaiswal AK, Katzenellenbogen BS: Transcriptional regulation of the human quinone reductase gene by antiestrogen-liganded estrogen receptor-alpha and estrogen receptor-beta. J Biol Chem 1998, 273:25443-25449
30. Wernert N, Gerdes J, Loy V, Seitz G, Scherr O, Dhom G: Investigations of the estrogen (ER-ICA-test) and the progesterone receptor in the prostate and prostatic carcinoma on immunohistochemical basis. Virchows Arch A Pathol Anat Histopathol 1988, 412:387-391
31. Schulze H, Claus S: Histological localization of estrogen receptors in normal and diseased human prostates by immunocytochemistry. Prostate 1990, 16:331-343
32. Ehara H, Koji T, Deguchi T, Yoshii A, Nakano M, Nakane PK, Kawada Y: Expression of estrogen receptor in diseased human prostate assessed by non-radioactive in situ hybridization and immunohistochemistry. Prostate 1995, 27:304-313
33. Bonkhoff H, Fixemer T, Hunsicker I, Remberger K: Estrogen receptor expression in prostate cancer and premalignant prostatic lesions. Am J Pathol 1999, 155:641-647
34. Taylor AH, Al Azzawi F: Immunolocalisation of oestrogen receptor beta in human tissues. J Mol Endocrinol 2000, 24:145-155
35. Fuqua SA, Schiff R, Parra I, Friedrichs WE, Su JL, McKee DD, Slentz-Kesler K, Moore LB, Willson TM, Moore JT: Expression of wild-type estrogen receptor beta and variant isoforms in human breast cancer. Cancer Res 1999, 59:5425-5428
36. McNeal JE: Prostatic microcarcinomas in relation to cancer origin and the evolution to clinical cancer. Cancer 1993, 71:984-991
37. Bostwick DG: High grade prostatic intraepithelial neoplasia: the most likely precursor of prostate cancer. Cancer 1995, 75:1823-1826
38. Stamey TA, McNeal JE, Yemoto CM, Sigal BM, Johnstone IM: Biological determinants of cancer progression in men with prostate cancer. JAMA 1999, 281:1395-1400
39. Gustafsson JA: An update on estrogen receptors. Semin Perinatol 2000, 24:66-69
40. Harlow E, Lane D. Antibodies: A Laboratory Manual. New York, Cold Spring Harbor Laboratory, 1988, pp 139-242
41. Leav I, McNeal JE, Kwan PW, Komminoth P, Merk FB: Androgen receptor expression in prostatic dysplasia (prostatic intraepithelial neoplasia) in the human prostate: an immunohistochemical and in situ hybridization study. Prostate 1996, 29:137-145
42. Bonkhoff H, Remberger K: Widespread distribution of nuclear androgen receptors in the basal cell layer of the normal and hyperplastic human prostate. Virchows Arch A Pathol Anat Histopathology 1993, 422:35-38
43. Gleave ME, Chung LW: Stromal-epithelial interaction affecting prostate tumor growth and hormonal responsiveness. Endocrinol-Related Cancer 1995, 2:243-265
44. Hall JM, McDonnell DP: The estrogen receptor beta-isoform (ERbeta) of the human estrogen receptor modulates ERalpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens. Endocrinology 1999, 140:5566-5578
45. Li LC, Yen CC, Nojima D, Dahiya R: Cloning and characterization of human estrogen receptor beta promoter. Biochem Biophys Res Commun 2000, 275:682-689
46. McNeal JE, Leav I, Alroy J, Skutelsky E: Differential lectin staining of central and peripheral zones of the prostate and alterations in dysplasia. Am J Clin Pathol 1988, 89:41-48
47. McNeal JE, Redwine EA, Freina FS, Stamey TA. Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread. Am J Surg Pathol 1988, 12:897-906
48. Foley EF, Jazaeri AA, Shupnik MA, Jazaeri O, Rice LW: Selective loss of estrogen receptor beta in malignant human colon. Cancer Res 2000, 60:245-248
49. Culig Z, Hobisch A, Bartsch G, Klocker H: Androgen receptor - an update of mechanisms of action in prostate cancer, Urol Res 2000, 28:211-219
50. Ruizeveld de Winter JA, Janssen PJ, Sleddens HM, Verleun-Mooijman MC, Trapman J, Brinkmann AO, Santerse AB, Schroder FH, van der Kwast TH: Androgen receptor status in localized and locally progressive hormone refractory human prostate cancer. Am J Pathol 1994, 144:735-746
51. Yomeda T: Cellular and molecular mechanisms of breast and prostate cancer metastasis to bone. Eur J Cancer 1998, 34:240-245